Ftse Mib
34.825,01
-1,62%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
70.099,99
5,77%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Angion Biomedica Corporation (ANGN) Angion Biomedica Corporation (ANGN) Notizie

ANGN

Angion Biomedica (ANGN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANGN
DataOraFonteTitoloSimboloCompagnia
29/04/202413:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
05/04/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
29/03/202420:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
29/03/202420:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
29/03/202418:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202421:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
20/03/202421:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
05/01/202422:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
13/11/202314:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
12/08/202303:13Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
07/07/202315:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
14/06/202322:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANGNAngion Biomedica Corporation
14/06/202320:43Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANGNAngion Biomedica Corporation
12/06/202323:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202323:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANGNAngion Biomedica Corporation
05/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANGNAngion Biomedica Corporation
01/06/202314:00GlobeNewswire Inc.Angion Biomedia Corp. Announces 1-for-10 Reverse Stock SplitNASDAQ:ANGNAngion Biomedica Corporation
24/05/202312:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANGNAngion Biomedica Corporation
10/05/202322:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202322:46Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ANGNAngion Biomedica Corporation
28/04/202322:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANGNAngion Biomedica Corporation
17/03/202321:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANGNAngion Biomedica Corporation
14/02/202322:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANGNAngion Biomedica Corporation
17/01/202311:00GlobeNewswire Inc.Elicio Therapeutics and Angion Enter into Definitive Merger AgreementNASDAQ:ANGNAngion Biomedica Corporation
22/12/202203:50GlobeNewswire Inc.Angion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsNASDAQ:ANGNAngion Biomedica Corporation
15/08/202222:05GlobeNewswire Inc.Angion Provides Corporate Update and Reports Second Quarter 2022 Financial ResultsNASDAQ:ANGNAngion Biomedica Corporation
26/07/202212:17TipRanksH.C. Wainwright Reiterates Their Hold Rating on Angion Biomedica (ANGN)NASDAQ:ANGNAngion Biomedica Corporation
25/07/202222:30GlobeNewswire Inc.Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder ValueNASDAQ:ANGNAngion Biomedica Corporation
29/06/202222:05GlobeNewswire Inc.Angion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney DiseaseNASDAQ:ANGNAngion Biomedica Corporation
27/05/202222:43Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ANGNAngion Biomedica Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANGN

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
BPSO
Banca Popolare di Sondrio
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network